These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones. Piccinelli G, Gargiulo F, Biscaro V, Caccuri F, Caruso A, De Francesco MA. Infect Genet Evol; 2017 Jan; 47():64-67. PubMed ID: 27884651 [Abstract] [Full Text] [Related]
6. Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species. Song J, Qiao Y, Kong Y, Ruan Z, Huang J, Song T, Zhang J, Xie X. J Med Microbiol; 2015 Nov; 64(11):1315-1320. PubMed ID: 26243148 [Abstract] [Full Text] [Related]
12. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila. Almahmoud I, Kay E, Schneider D, Maurin M. J Antimicrob Chemother; 2009 Aug; 64(2):284-93. PubMed ID: 19474069 [Abstract] [Full Text] [Related]
13. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Lee JK, Lee YS, Park YK, Kim BS. Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307 [Abstract] [Full Text] [Related]
14. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. Pu XY, Pan JC, Wang HQ, Zhang W, Huang ZC, Gu YM. J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378 [Abstract] [Full Text] [Related]
19. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. Canton R, Morosini M, Enright MC, Morrissey I. J Antimicrob Chemother; 2003 Dec; 52(6):944-52. PubMed ID: 14585861 [Abstract] [Full Text] [Related]